Literature DB >> 8024199

Mechanisms of action of the p53 tumor suppressor and prospects for cancer gene therapy by reconstitution of p53 function.

K Roemer1, T Friedmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8024199     DOI： 10.1111/j.1749-6632.1994.tb21718.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  4 in total

1.  Effects of a histone deacetylase inhibitor, sodium butyrate, on 53-kDa protein expression and sensitivity to anticancer drugs of pancreatic cancer cells.

Authors:  Masaki Kitazono; Hiroyuki Shinchi; Sumiya Ishigami; Shinichi Ueno; Shoji Natsugoe
Journal:  Curr Ther Res Clin Exp       Date:  2010-06

2.  Synergistic growth inhibition by combination of adenovirus mediated p53 transfer and cisplatin in ovarian cancer cell lines.

Authors:  Sang Young Ryu; Kidong Kim; Woo Sik Lee; Hee Chung Kwon; Kee Ho Lee; Chang Min Kim; Soon-Beom Kang
Journal:  J Gynecol Oncol       Date:  2009-03-31       Impact factor: 4.401

Review 3.  Antisense oncogene and tumor suppressor gene therapy of cancer.

Authors:  W W Zhang
Journal:  J Mol Med (Berl)       Date:  1996-04       Impact factor: 4.599

Review 4.  E2F1 death pathways as targets for cancer therapy.

Authors:  B M Pützer
Journal:  J Cell Mol Med       Date:  2007 Mar-Apr       Impact factor: 5.310
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.